大麻中毒は,小火傷患者の栄養状態に影響を与えない
Sarah Wang1, Eloise Stanton2, Amara Emeh1
1Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
まとめ
灼熱患者の大麻の使用は,栄養状態や回復結果に有意な影響を及ぼさなかった. この研究では,大麻中毒と,焼け死者のプレアルブミンまたはアルブミンレベルとの間に関連性がないことが判明しました.
科学分野:
- 医学研究 医学研究
- 栄養科学とは,栄養科学である.
- トラウマケアのケア
背景:
- 灼熱患者は重度の超新陳代謝を経験し,栄養失調のリスクが高まり,回復に影響を及ぼします.
- 大麻は食欲を刺激することが知られているが,火傷患者の栄養におけるその役割は不明である.
- 栄養の影響を理解することは,灼熱治療の成果を改善するために不可欠です.
研究 の 目的:
- 大人の灼熱患者における大麻使用と栄養状態の関連性を調査する.
- カンナビス中毒がプレアルブミンやアルブミンなどの重要な栄養マーカーに影響するかどうかを判断する.
- カナビス使用と患者からの結果の間の関係を探求するため,火傷後の怪我.
主な方法:
- 2015年から2024年までの間に入院した成人灼熱患者 (20%未満のTBSA) の遡及的研究.
- 大麻陽性患者と大麻陰性対照群の1:1の比較に一致した.
- 人口統計,燃焼特性,栄養マーカー (プレアルブミン,アルブミン),およびアウトカムに関する分析.
主要な成果:
- 大麻使用者と対照群の間で,人口統計や結果の有意な差異はありません.
- カンナビス中毒は,入院前アルバミンまたはアルバミンレベルと有意に関連しませんでした.
- プレアルバミンまたはアルバミンのピークレベルに達するまでの時間における有意な変動は観察されなかった.
結論:
- カナビス中毒は,入院時に火傷患者の栄養状態に大きな影響を与えるようには見えません.
- 大規模なコホートでのさらなる研究は,大麻と火傷回復の複雑な関係を完全に解明するために必要です.
- 年齢と人種がアルバミンのレベルと関連していることが判明し,栄養状態に影響を与える他の要因を強調しました.
関連する概念動画
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
806
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
806
Burn Injuries
4.7K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.7K
CNS Depressants: Alcohol and Nicotine
1.4K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.4K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
285
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
285
Factors Affecting Drug Response: Overview
3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Drug Toxicity: Risk factors
27
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
27


